IS2435B - Lyfjafræðileg loftúðasamsetning - Google Patents

Lyfjafræðileg loftúðasamsetning

Info

Publication number
IS2435B
IS2435B IS4974A IS4974A IS2435B IS 2435 B IS2435 B IS 2435B IS 4974 A IS4974 A IS 4974A IS 4974 A IS4974 A IS 4974A IS 2435 B IS2435 B IS 2435B
Authority
IS
Iceland
Prior art keywords
aerosol composition
pharmaceutical aerosol
pharmaceutical
composition
aerosol
Prior art date
Application number
IS4974A
Other languages
English (en)
Icelandic (is)
Other versions
IS4974A (is
Inventor
Lewis David
Ganderton Davis
Meakin Brian
Ventura Paolo
Brambilla Gaetano
Garzia Raffaella
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2435(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of IS4974A publication Critical patent/IS4974A/is
Publication of IS2435B publication Critical patent/IS2435B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4974A 1997-06-13 1999-02-11 Lyfjafræðileg loftúðasamsetning IS2435B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (2)

Publication Number Publication Date
IS4974A IS4974A (is) 1999-02-11
IS2435B true IS2435B (is) 2008-10-15

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4974A IS2435B (is) 1997-06-13 1999-02-11 Lyfjafræðileg loftúðasamsetning

Country Status (44)

Country Link
EP (2) EP0920302B2 (en:Method)
JP (1) JP4380802B2 (en:Method)
KR (1) KR100546239B1 (en:Method)
CN (1) CN1138532C (en:Method)
AR (1) AR012977A1 (en:Method)
AT (1) ATE222751T1 (en:Method)
AU (1) AU729966B2 (en:Method)
BG (1) BG63906B1 (en:Method)
BR (1) BR9805993B1 (en:Method)
CA (1) CA2263445C (en:Method)
CO (1) CO4940408A1 (en:Method)
CZ (1) CZ295521B6 (en:Method)
DE (1) DE69807420T3 (en:Method)
DK (1) DK0920302T4 (en:Method)
DZ (1) DZ2516A1 (en:Method)
EA (1) EA001259B1 (en:Method)
EE (1) EE03664B1 (en:Method)
ES (1) ES2182351T5 (en:Method)
GB (1) GB2326334A (en:Method)
GE (1) GEP20012462B (en:Method)
HR (1) HRP980317B1 (en:Method)
HU (1) HU228487B1 (en:Method)
ID (1) ID21491A (en:Method)
IL (1) IL128484A (en:Method)
IN (1) IN189317B (en:Method)
IS (1) IS2435B (en:Method)
IT (1) IT1293803B1 (en:Method)
MA (1) MA26507A1 (en:Method)
ME (2) MEP44008A (en:Method)
MY (1) MY119074A (en:Method)
NO (1) NO327775B1 (en:Method)
NZ (1) NZ334149A (en:Method)
PL (1) PL193721B1 (en:Method)
PT (1) PT920302E (en:Method)
RS (1) RS51274B (en:Method)
SA (1) SA98190821B1 (en:Method)
SI (1) SI0920302T2 (en:Method)
SK (1) SK284430B6 (en:Method)
TN (1) TNSN98087A1 (en:Method)
TR (1) TR199900288T1 (en:Method)
TW (1) TW555570B (en:Method)
UA (1) UA70289C2 (en:Method)
WO (1) WO1998056349A1 (en:Method)
ZA (1) ZA985136B (en:Method)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
FR2798290B1 (fr) 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
JP2003514841A (ja) * 1999-11-23 2003-04-22 グラクソ グループ リミテッド サルメテロールの医薬製剤
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
TR200401980T4 (tr) 2001-07-02 2004-09-21 Chiesi Farmaceutici S.P.A. Aerosol olarak uygulama için en uygun hale getirilmiş tobramisin formülasyonu
EP2201964B1 (en) 2002-03-01 2018-08-08 CHIESI FARMACEUTICI S.p.A. Formoterol superfine formulation
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
AU2003293528A1 (en) * 2003-02-04 2004-09-06 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
PL1608336T3 (pl) * 2003-03-20 2008-09-30 Boehringer Ingelheim Pharmaceuticals Inc Preparat do podawania przez ciśnieniowy inhalator dozujący (MDI) zawierający hydrofluoroalkany jako gaz pędny
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
EP1809243B2 (de) 2004-07-02 2022-06-08 Boehringer Ingelheim International GmbH Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
MX2010005036A (es) * 2007-11-07 2010-05-27 Astrazeneca Ab Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
EP2613829B1 (en) * 2010-09-06 2022-06-29 Chiesi Farmaceutici S.p.A. Metered-dose inhaler
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (fr) 2016-03-31 2021-04-28 Chiesi Farm Spa Dispositif d'inhalation d'aérosol
MY210122A (en) * 2016-09-19 2025-08-28 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293929C (en) † 1986-03-10 1992-01-07 Kurt Burghart Pharmaceutical composition containing nifedipine
EP0259383B1 (de) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Pharmazeutikum sowie verfahren zu seiner herstellung
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2769925B2 (ja) † 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES2158911T5 (es) † 1991-06-10 2009-12-09 Schering Corporation Formulaciones en aerosol sin clorofluorocarbonos.
CA2111003A1 (en) † 1991-06-10 1992-12-23 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
DK1086688T3 (da) * 1991-12-18 2004-08-16 Minnesota Mining & Mfg Aerosolformuleringer til suspensioner
CA2151383C (en) * 1992-12-09 2005-02-08 Paul Donald Jager Stabilized medicinal aerosol solution formulation
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
CA2189351C (en) † 1994-05-13 2008-12-30 Stephen J. Farr Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
NZ336049A (en) † 1996-12-04 2000-09-29 Bioglan Ireland R & D Ltd Aersol device for administering pharmaceutical active agents in a solution of propellant, carrier and valve means for delivering this to the exterior of the container
CA2280099C (en) † 1997-02-05 2005-12-27 Jago Pharma Ag Medical aerosol formulations

Also Published As

Publication number Publication date
DE69807420T2 (de) 2003-05-08
HRP980317A2 (en) 1999-04-30
ME00333B (me) 2011-02-10
EE03664B1 (et) 2002-04-15
EA199900201A1 (ru) 1999-06-24
EE9900055A (et) 1999-08-16
ZA985136B (en) 1999-01-07
PL193721B1 (pl) 2007-03-30
EA001259B1 (ru) 2000-12-25
TR199900288T1 (xx) 1999-09-21
CO4940408A1 (es) 2000-07-24
HUP0001339A3 (en) 2000-10-30
BG63906B1 (bg) 2003-06-30
NO990594D0 (no) 1999-02-09
DZ2516A1 (fr) 2004-11-08
DE69807420T3 (de) 2006-11-16
EP0920302B1 (en) 2002-08-28
MEP44008A (en) 2011-02-10
PT920302E (pt) 2002-11-29
GEP20012462B (en) 2001-06-25
AU8626298A (en) 1998-12-30
MA26507A1 (fr) 2004-12-20
YU6999A (sh) 2000-03-21
NO327775B1 (no) 2009-09-21
HU228487B1 (en) 2013-03-28
UA70289C2 (uk) 2004-10-15
ID21491A (id) 1999-06-17
EP1219293A2 (en) 2002-07-03
IN189317B (en:Method) 2003-02-08
EP0920302A1 (en) 1999-06-09
EP0920302B2 (en) 2006-06-21
NO990594L (no) 1999-04-13
BG103221A (en) 1999-09-30
MY119074A (en) 2005-03-31
SK284430B6 (sk) 2005-04-01
CA2263445C (en) 2008-09-09
SI0920302T1 (en) 2002-12-31
IL128484A0 (en) 2000-01-31
WO1998056349A1 (en) 1998-12-17
ITMI971798A1 (it) 1999-01-28
EP1219293A3 (en) 2003-05-28
HRP980317B1 (en) 2002-06-30
SA98190821B1 (ar) 2006-11-19
KR100546239B1 (ko) 2006-01-26
CN1229355A (zh) 1999-09-22
AU729966B2 (en) 2001-02-15
ES2182351T5 (es) 2007-03-16
HUP0001339A2 (hu) 2000-09-28
TNSN98087A1 (fr) 2005-03-15
AR012977A1 (es) 2000-11-22
SI0920302T2 (sl) 2006-10-31
KR20000068171A (ko) 2000-11-25
TW555570B (en) 2003-10-01
RS51274B (sr) 2010-12-31
DK0920302T3 (da) 2002-12-23
GB2326334A (en) 1998-12-23
ATE222751T1 (de) 2002-09-15
DK0920302T4 (da) 2006-10-09
CN1138532C (zh) 2004-02-18
ES2182351T3 (es) 2003-03-01
DE69807420D1 (de) 2002-10-02
NZ334149A (en) 2000-07-28
IS4974A (is) 1999-02-11
HK1022271A1 (en) 2000-08-04
CZ46299A3 (cs) 1999-07-14
CA2263445A1 (en) 1998-12-17
PL331531A1 (en) 1999-07-19
IL128484A (en) 2004-09-27
BR9805993B1 (pt) 2009-05-05
CZ295521B6 (cs) 2005-08-17
IT1293803B1 (it) 1999-03-10
BR9805993A (pt) 1999-08-31
JP2000516965A (ja) 2000-12-19
SK17699A3 (en) 1999-07-12
JP4380802B2 (ja) 2009-12-09
GB9712434D0 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
DK0920302T3 (da) Farmaceutisk aerosolsammensætning
DK1073417T3 (da) Farmaceutisk aerosolformulering
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
DE69530325D1 (de) Aerosol-arzneiformulierungen
ID24654A (id) Formulasi farmasi omeprazola
EE9900545A (et) Farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
BR1100755A (pt) composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
SE9604299D0 (sv) Pharmaceutical composition
ID17133A (id) Komposisi farmasi
SE9601854D0 (sv) Farmaceutisk komposition